The main focus right now in the myeloma paradigm of treatment is, okay, how do we harness the best power of CAR-T? We're doing it later in the treatment of myeloma. We've tried to move it earlier, and ...

A fundraiser has been launched to help a young girl from Kerry seek cancer treatment abroad following her neuroblastoma ...

Discontinuation of first-line DMTs among patients with stable MS for at least 5 years may lead to an increased risk for recurrence.

Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less effective drug.

While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...

But thanks to your generous support of St. Jude Children’s Research Hospital over the years, the survival rate has increased ...

Matt and Emma Willis are teaming up with some of Britain's leading therapists to explore how they help overcome the ...

The "Together for Fiadh" GoFundMe campaign is trying to raise funds so Fiadh Ronan can access costly clinical trials in the ...

Although the treatment of myeloma has changed dramatically after the readout of many recent trials, key unanswered questions ...

Death metal often seems to belong to a bygone time, whether that’s the white-sneakered ’80s that birthed the genre or much, ...

Dr. Heidenreich notes that among the 86% of seminoma CSI patients, 15-30% relapse, of which 95% relapse in the retroperitoneum, nearly all relapses have good prognosis, and these patients are now CS ...

In the initial publication in 2021, the KETYNOTE-564 trial demonstrated that adjuvant pembrolizumab was associated with ...